Wednesday, 7 June 2017

Quercetin hợp chất kháng Hep G2, MCF7 & MDA‐MB‐231

Investigation of the anti-cancer effect of quercetin on HepG2 cells in vivo

Induction of apoptotic cell death by the dietary quercetin in MCF-7 and ...

Quercetin hợp chất kháng Hep G2,  MCF7 & MDA‐MB‐231

Quercetin

From Wikipedia, the free encyclopedia
Quercetin
Skeletal formula of quercetin
Ball-and-stick model of the quercetin molecule
Names
Pronunciation/ˈkwɜːrstn/
IUPAC name
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one
Other names
5,7,3′,4′-flavon-3-ol, Sophoretin, Meletin, Quercetine, Xanthaurine, Quercetol, Quercitin, Quertine, Flavin meletin
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
DrugBank
ECHA InfoCard100.003.807
KEGG
PubChem CID
UNII
Properties
C15H10O7
Molar mass302.236 g/mol
Appearanceyellow crystalline powder[1]
Density1.799 g/cm3
Melting point316 °C (601 °F; 589 K)
Practically insoluble in water; soluble in aqueous alkaline solutions[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
 verify (what is Yes ?)
Infobox references

UV visible spectrum of quercetin, with lambda max at 369 nm.
Quercetin is a plant polyphenol from the flavonoid group, found in many fruits, vegetables, leaves, and grains. It can be used as an ingredient in supplements, beverages, or foods.

Health effects[edit]

While quercetin supplements have been promoted for prevention and treatment of cancer, "there is no reliable clinical evidence that quercetin can prevent or treat cancer in humans".[2] Also, there is no conclusive evidence that consuming foods rich in quercetin reduces the risk of cancer or any other disease.[3]
Quercetin supplements have also been promoted for the treatment of a wide spectrum of other diseases.[4] However, the European Food Safety Authority evaluated possible health claims associated with consumption of quercetin, and found that no cause-and-effect relationship has been established for any physiological effect in human health or diseases.[5]

Drug interactions[edit]

Quercetin is contraindicated with some antibiotics; it may interact with fluoroquinolones (a class of antibiotics), as quercetin competitively binds to bacterial DNA gyrase. Whether this inhibits or enhances the effect of fluoroquinolones is not certain.[6]
As paclitaxel is metabolized primarily by CYP2C8, its bioavailability may be increased unpredictably by quercetin, potentially leading to harmful side effects.[7][8]

Occurrence[edit]

Quercetin is a flavonoid widely distributed in nature. The name has been used since 1857, and is derived from quercetum(oak forest), after Quercus.[9][10] It is a naturally occurring polar auxin transport inhibitor.[11]
Quercetin is one of the most abundant dietary flavonoids with an average daily consumption of 25–50 mgs.[12]
Foods containing quercetinQuercetin (mg/100g of edible portion)
capers, raw234[13]
capers, canned173[13]
lovage170[13]
dock like sorrel86[13]
radish leaves70[13]
carob fiber58[13]
dill55[14] (48-110)[15]
cilantro53[13]
Hungarian wax pepper51[13]
fennel leaves48.8[13]
onion, red32[16]
radicchio31.5[13]
watercress30[16]
buckwheat23[17]
kale23[16]
chokeberry19[16]
cranberry15[16]
lingonberry13[16]
plums, black12[16]
cow peas11[16]
sweet potato10[16]
blueberry, cultivated8[16]
sea buckthorn berry8[16]
rowanberry7[16]
crowberry5[16]
prickly pear cactus fruits5[16]
applesRed Delicious4[16]
broccoli3[16]
bilberry3[16]
tea, black or green Camellia sinensis2[16]
red kidney beans, raw (powdered)0.0603 +/- 0.0307[18]
In red onions, higher concentrations of quercetin occur in the outermost rings and in the part closest to the root, the latter being the part of the plant with the highest concentration.[19] One study found that organically grown tomatoes had 79% more quercetin than non-organically grown fruit.[20] Quercetin is present in various kinds of honey from different plant sources.[21]

Biosynthesis[edit]

In plants, phenylalanine is converted to 4-coumaroyl-CoA in a series of steps known as the general phenylpropanoid pathway using phenylalanine ammonia-lyasecinnamate-4-hydroxylase, and 4-coumaroyl-CoA-ligase.[22] One molecule of 4-coumaroyl-CoA is added to three molecules of malonyl-CoA to form tetrahydroxychalcone using 7,2′-dihydroxy-4′-methoxyisoflavanol synthase. Tetrahydroxychalcone is then converted into naringenin using chalcone isomerase.
Naringenin is converted into eriodictyol using flavanoid 3′-hydroxylase. Eriodictyol is then converted into dihydroquercetin with flavanone 3-hydroxylase, which is then converted into quercetin using flavonol synthase.[22]

Glycosides[edit]


3-O-Glycosides of quercetin
Quercetin is the aglycone form of a number of other flavonoid glycosides, such as rutin and quercitrin, found in citrus fruit, buckwheat and onions. Quercetin forms the glycosides quercitrin and rutin together with rhamnose and rutinose, respectively. Likewise guaijaverin is the 3-O-arabinosidehyperoside is the 3-O-galactosideisoquercitin is the 3-O-glucoside and spiraeoside is the 4′-O-glucoside. CTN-986 is a quercetin derivative found in cottonseeds and cottonseed oil. Miquelianin is the quercetin 3-O-β-D-glucuronopyranoside.[23]

Rutin degradation pathway[edit]

The enzyme quercitrinase can be found in Aspergillus flavus.[24] This enzyme hydrolyzes the glycoside quercitrin to release quercetin and L-rhamnose. It is an enzyme in the rutin catabolic pathway[25]

Pharmacology[edit]

Pharmacokinetics[edit]

The bioavailability of quercetin in humans is low and highly variable (0-50%), and is rapidly cleared with an elimination half-life of 1–2 hours after ingesting quercetin foods or supplements.[26] Following dietary ingestion, quercetin undergoes rapid and extensive metabolism that makes the biological effects presumed from in vitrostudies unlikely to apply in vivo.[27][28]

Metabolism[edit]

In rats, quercetin did not undergo any significant phase I metabolism.[29] In contrast, quercetin did undergo extensive phase II (conjugation) to produce metabolites that are more polar than the parent substance and hence are more rapidly excreted from the body. The meta-hydroxyl group of catechol is methylated by catechol-O-methyltransferase. Four of the five hydroxyl groups of quercetin are glucuronidated by UDP-glucuronosyltransferase. The exception is the 5-hydroxyl group of the flavonoid ring which generally does not undergo glucuronidation. The major metabolites of orally absorbed quercetin are quercetin-3-glucuronide3'-methylquercetin-3-glucuronide, and quercetin-3'-sulfate.[29][30]

In vitro pharmacology[edit]

Quercetin has been reported to inhibit the oxidation of other molecules and hence is classified as an antioxidant.[27][30] Quercetin contains a polyphenolic chemical substructure that stops oxidation by acting as a scavenger of free radicals that are responsible for oxidative chain reactions.[31]
Quercetin also activates or inhibits the activities of a number of proteins.[32] For example, quercetin is a non-specific protein kinase enzyme inhibitor.[27][30] Quercetin has also been reported to have estrogenic (female sex hormone like) activities by activating estrogen receptors. Quercetin activates both estrogen receptor alpha (ERα) and beta (ERβ)[33] with binding IC50s of 1015 nM and 113 nM respectively. Hence quercetin is somewhat ERβ selective (9 fold) and is roughly two to three orders of magnitude less potent than the endogenous estrogenic hormone 17β-estradiol.[34][35] In human breast cancer cell lines, quercetin has also been found to act as an agonist of the G protein-coupled estrogen receptor (GPER).[36][37]

Clinical research[edit]

Although quercetin is under basic and early-stage clinical research for a variety of disease conditions,[38][39] there is insufficient evidence on whether quercetin promotes DNA repair in humans.[5] Claims about the role of quercetin in liver and kidney system function, mental performance or cardiovascular health in the human body are insufficiently defined to draw any conclusions.[5] The US FDA has issued warning letters to emphasize that quercetin is not a defined nutrient nor an antioxidant, cannot be assigned a dietary content level, and is not regulated as a drug to treat any human disease.[40]

See also[edit]

Hep G2 is a human liver cancer cell line.

Hep G2

From Wikipedia, the free encyclopedia
Hep G2 Cells
Hep G2 is a human liver cancer cell line.
Hep G2 is a perpetual cell line which was derived from the liver tissue of a 15-year-old Caucasian American male with a well-differentiated hepatocellular carcinoma. These cells are epithelial in morphology, have a modal chromosome number of 55, and are not tumorigenic in nude mice.[1] The cells secrete a variety of major plasma proteins, e.g., albumintransferrin, and the acute-phase proteins fibrinogenalpha 2-macroglobulinalpha 1-antitrypsintransferrin, and plasminogen.[citation needed] They have been grown successfully in large-scale cultivation systems. Hepatitis B virus surface antigens have not been detected. HepG2 will respond to stimulation with human growth hormone.[citation needed]
HepG2 cells are a suitable in vitro model system for the study of polarized human hepatocytes. (Another well-characterized polarized hepatocyte cell line is the rat hepatoma-derived hybrid cell line WIF-B[2]). With the proper culture conditions, HepG2 cells display robust morphological and functional differentiation with a controllable formation of apical and basolateral cell surface domains (van IJzendoorn et al., 1997; 2000, etc.) that resemble the bile canalicular (BC) and sinusoidal domains, respectively, in vivo.
Because of their high degree of morphological and functional differentiation in vitro, HepG2 cells are a suitable model to study the intracellular trafficking and dynamics of bile canalicular and sinusoidal membrane proteins and lipids in human hepatocytes in vitro.[citation needed] This can be important for the study of human liver diseases that are caused by an incorrect subcellular distribution of cell surface proteins, e.g., hepatocanalicular transport defects such as Dubin-Johnson Syndrome and progressive familial intrahepatic cholestasis (PFIC), and familial hypercholesterolemia.[citation needed] HepG2 cells and their derivatives are also used as a model system for studies of liver metabolism and toxicity of xenobiotics[citation needed], the detection of environmental and dietary cytotoxic and genotoxic (and thus cytoprotective, anti-genotoxic, and cogenotoxic) agents,[3] understanding hepatocarcinogenesis[citation needed], and for drug targeting studies[citation needed]. HepG2 cells are also employed in trials with bio-artificial liver devices[citation needed].

HepG2 in Cell Culture

HepG2 (liver hepatocellular carcinoma): cell culture and transfection ...

HepG2 (liver hepatocellular carcinoma): cell culture and transfection protocol

HepG2 in Cell Culture

HepG2 Cell Line Characteristics

HepG2 is an immortalized cell line consisting of human liver carcinoma cells, derived from the liver tissue of a 15-year-old Caucasian male who had a well-differentiated hepatocellular carcinoma. Hepatocellular carcinoma is the fifth most-common cancer worldwide. The morphology of HepG2 cells is epithelial and contains 55 chromosome pairs. HepG2 cells can be grown successfully at a large scale, and secrete many plasma proteins, such as transferrin, fibrinogen, plasminogen and albumin. They can be stimulated with human growth hormone. HepG2 cells are adherent, epithelial-like cells growing as monolayers and in small aggregates.
Copyright picture from Altogen.com. Reproduced with permission from Altogen Biosystems.

HepG2 Cytogenetics

HepG2 cells are hyperdiploid karyotype – 52(47-54)<2n>XY, +2, +14, +17, +20, +2mar, t(1;21) (p22.2;p11-12), i(17q)/der(17)t(17;17)(p11;q11)

HepG2 Cell Culturing Protocol

HepG2 complete medium

Eagle’s Minimum Essential Medium (EMEM) supplemented with 10% FBS; DMEM and RPMI1640 are also alternatives that work well. Aspirate and add fresh culture medium every 2-3 days.  HepG2 cell doubling time is 48 hours.
  1. To passage cells, rinse cell monolayer with 1x PBS twice and add pre-warmed (37°C) 0.05% Trypsin-EDTA solution to cover the bottom of the flask; incubate for 5 – 7 minutes
  2. As cells detach, neutralize the Trypsin by adding 4x volume of complete growth medium with 10% FBS and gently resuspend the cells by pipetting
  3. To avoid clumping do not agitate the cells by shaking the flask while waiting for detachment
  4. Split cells 1:4 every 3 days or 1:8 every 6 days
  5. Cultures should be incubated at 37°C in a humidified atmosphere with 5% CO2

Subculture Troubleshooting Procedures

Low cell viability after passaging:

  • Dissociation agent left on cells too long; only expose cells to dissociation agent long enough for cell detachment
  • Pipette gently during passaging procedures; cells are fragile when exposed to dissociation agents

Cells are difficult to detach:

  • Cell-to-cell junctions are tight due to cell growth being 100% confluent and dissociation agent cannot reach cell interface; subculture cells before confluent
  • Use higher concentration of dissociation agent; incubate flask at 37°C to increase enzymatic activity
  • Wash flask twice with sterile 1x PBS prior to addition of the dissociation agent

Clumps form after detachment:

  • Cells were centrifuged too fast; do not spin cells faster than 100 x g to pellet
  • Place the flask or vial on ice to decrease aggregation before use

HepG2 Cell Line Derived Xenograft

HepG2 cells are inoculated in immunocompromised mice to create the HepG2 Cell Line Derived Xenograft (CDX) mouse model. The HepG2 xenograft of human hepatocellularcarcinoma (HCC) enables studies targeting antiangiogenesis (i.e. rapamycin, bevacizumab) or tumor growth inhibition (e.g. sorafenib).

Stable Cell Line Generation

HepG2 cells have been demonstrated to be Neomycin G418 resistant (400 µg/mL). Development of HepG2 stable cell line services are provided by Altogen Labs CRO
*NOTE: All IP rights to the HepG2 cell line belongs solely to the Wistar Institute.

HepG2 Resources

HepG2 cells Forum: Research methods & Laboratory techniques: Link

Friday, 21 April 2017

Momordica cochinchinensis dược liệu kháng A549 (tế bào adenocarcinomic nhân phế nang đấy biểu mô)

Gac


Momordica cochinchinensis.
Le Momordica cochinchinensis, couramment appelé le Gac, est un fruit d'Asie du Sud que l'on trouve principalement dans les régions du Sud de la Chine mais aussi en Thaïlande, au Laos, au Myanmar, au Cambodge, au Vietnam ainsi qu'au Nord-Est de l'Australie.